Back

How early can we identify differences in regional myocardial deformation after mavacamten initiation for hypertrophic obstructive cardiomyopathy: a pilot study

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - imaging (2) Imaging HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Filip Loncaric

University Hospital Centre Zagreb, Zagreb (Croatia)

5 More presentations in this session

Presentation thumbnail
Contribution of speckle tracking in myocardial detection damage in chronic obstructive pulmonary disease patients
Associate Professor I. Chamtouri (Al Munastir, TN)
Abstract Slides Video
Presentation thumbnail
Correlation of Nt-proBNP with echocardiographic parameters related to right ventricular load in patients with chronic obstructive pulmonary disease
Doctor I. Bojovski (Skopje, MK)
Abstract Slides Video
Presentation thumbnail
Relationship between VEXUS grade and CA-125 in decompansated heart failure
Doctor V. Kozluca (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Myocardial features, intracardiac thrombosis and coronary artery disease assessment with cardiac computed tomography in cardiac amyloidosis (MYOAMY CT): a proof-of-concept study
Doctor Y. Ferrari Chen (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Right ventricle free-wall longitudinal strain prognostic role in the durable mechanical circulatory support candidate patients
Doctor L. Martini (Siena, IT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - imaging (2)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Effect of Mavacamten on left ventricular diastolic function and left atrial function in obstructive hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Effect of mavacamten on left ventricular myocardial volume, strain and tissue characteristics in patients with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Changes in global myocardial work indices during mavacamten treatment in obstructive hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources